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General Introduction 
 
 
Nosocomial infections represent a serious public health problem; annual 
incidence in the United States is estimated in 2 million cases or about 10% of the 
hospitalized patients.  In developing countries, the rates of nosocomial infections are 
3 to 20 times higher than those in industrialized countries (1); and represent a major 
cause of death in infants.  Reports in South America indicate that annual incidence of 
nosocomial infections in Colombia are around 300,000 per year and in Peru around 
200,000 per year. There is no an official report in Ecuador because underreporting is 
common (2).  
Nosocomial infections are currently a major health problem because they are 
major causes of morbidity and mortality, and cause high costs (3). Due to the use of 
large amounts of anti-microbials in the hospital environments, nosocomial bacteria 
tend to acquire multi antimicrobial resistance; therefore, treatments are difficult and 
costly. United States spends 4,500 million dollars average each year. In Ecuador a 
retrospective study was conducted at the hospital Vozandes (from 1999 to 2000) 
showing that the additional cost per patient of a ventilator associated pneumonia 
averaged $ 1,349 (3). Another study at the Military Hospital in Quito reported that 
nosocomial infections of the nervous system add an additional cost of $ 4,045 per 
patient, urinary tract infections $ 536 per per patient,  and bacteremia $ 603 per 
patient (3). 
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The bacterial adaptation to different environments is the result of evolutionary 
processes in the constantly changing bacterial genomes. As consequence, 
nosocomial infections are the result of multiple factors that favor the microbial 
proliferation and colonization in healthcare centers and personnel. For these reasons, 
nosocomial pathogens tend to acquire virulence and antimicrobial multi resistance 
phenotypes (4).  
Surveillance is critical in the fight against nosocomial infections, because it 
allows to assess the real impact of these infections and the risk factors associated to 
them. This information enables better decision-making for prevention and control 
measures (5) .Despite its benefits, many times this type of studies are a big challenge 
for hospital medical practice (5,6).  
Molecular typing is an important epidemiological tool which utilizes analysis of 
molecules in order to identify the relationship of isolates and thus allows the detection 
of outbreaks, cross-transmission of pathogens, identification of the source of 
infection, recognition particularly virulent strains, and monitoring of vaccination 
programs (6). Molecular epidemiology studies basically the genetic lineage of 
pathogens in order to establish their patterns of dissemination. 
There are several molecular typing techniques that analyze macro or micro 
genome diversity. The micro diversity techniques are focused in comparison of one or 
few genes to infer clonality (phylogenetic relationships) among isolates. Techniques 
such as restriction length fragment polymorphism (RLFP) using Southern blot of a 
gene or RFLP of polymerase chain reaction (PCR) products are good examples of 
this category. The macro diversity techniques analyze whole genome variations and 
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are useful to study endemic bacteria and outbreaks (6).  There are a number of 
molecular typing procedures, and their utility depends of the characteristics of the 
genome. The PCR reactions of repetitive sequences are useful and sensible, but do 
not have a good reproducibility. Multilocus Assay Typing (MLST) is an recently 
developed approach which uses the sequence of housekeeping genes, and it has the 
advantage of lacking variation between laboratories. It allows to develop phylogenetic 
trees, but the selection of the genes to be analyzed is crucial (6). The other 
advantage of MLST is the existence of databases which locate of the clonally related 
strains around the world; however it is an expensive approach (6). 
Pulsed-field gel electrophoresis (PFGE) is a technique that measure macro-
diversity of bacterial genomes through the difference in length of DNA restriction 
fragments (around 4-MB) band patterns. The movement of these bands is facilitated 
by intermittent polarity changes. The restriction enzyme and the periodicity of electric 
pulses depend of bacteria species and bands size (6). PFGE is a highly reproducible 
method with good discriminatory power, relatively easy to perform and interpret, 
which can be used in many bacterial species and it is considered a standard 
technique for analyzing genomic DNA in epidemiological studies (6). The device type 
most frequently used is a Contour-clamped homogeneous electric field (CHEF), 
which has electrodes arranged in hexagonal form. 
Finally, it is important  to mention that the cost of implementing a molecular 
typing program in a 300 beds hospital is around $400,000 USD per year; however, 
these costs led to a savings of $5.00 for each dollar spent, for the high reduction of 
nosocomial infections (6) . 
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Staphylococcus aureus  
Microbiological Characteristics  
 
Staphylococcus aureus is a Gram-positive coccus that belongs to the 
Micrococcaceae family. The species of Staphylococcus genera have between 0,5 – 1 
m diameter, are immobile, facultative anaerobes, do not form spores and have no 
capsule. When is viewed through a microscope appears as grape-like clusters, and it 
is the origin of its name Staphilé that means grape clusters. When it is cultivated on 
blood agar plates, forms large, round, and golden colonies (this golden appearance is 
the reason because is named aureus), and sometimes it produces hemolysis (7).  
S. aureus is catalase positive, this test is useful to distinguish staphylococci 
from enterococci and streptococci. S. aureus is also coagulase-positive, and this test 
is useful to distinguish S. aureus from the other Staphylococcus species. Another 
main characteristic is that it can ferment the Manitol sugar; for this reason, it grows 
yellow in manitol medium (7). 
S. aureus is as a commensal of human skin and nasopharynx, but it can 
survive also in domestic animals such as dogs, chickens, cats, and horses. The 
importance of these bacteria is because several strains can develop virulent forms 
and act as opportunistic pathogens (8). 
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Genetic Characteristics  
 
In the genome of this bacterium have been characterized both pathogenicity 
islands and multiple antibiotic resistance genes (9). In Staphylococcus aureus 
genome has been identified multiple pathogenicity islands transferred through phage, 
have been characterized 4 phages (φ80, φ11, φ12 and φ147) that carry several types 
of different pathogenicity islands like the toxic shock syndrome exotoxin (TSST-1), the 
genes saPIbov12 and saPIbov2, which encode a protein associated to biofilm 
formation.  
The resistance against betalactams occurs by changes in proteins involved 
with peptidoglycan synthesis or by synthesis of betalactamases. (9). It has been 
recently determined that the stimulus to some antibiotics such as betalactams, trigger 
the SOS response in Staphylococcus aureus through the synthesis of the protein 
RecA and hence inhibiting LexA repressive mechanisms. This activates 
recombination mechanisms which activate of the lytic phases of these phages (10). 
Within the multiple virulence genes of S. aureus it has been characterized the 
operon agr which encodes for a quorum sensing system mediated by a two 
components system, AgrD which is processed and exported by the conveyor AgrB to 
produce the signal peptide AIP (11). With an AIP increasing concentration, the 
histidine kinase AgrC acts as sensor, and produces the phosphorylation of response 
regulator AgrA that promotes the transcription of:  
1. The promoter 2 that regulates RNA II transcription where the proteins encoded 
operon agr2. (11) 
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2. The promoter 3 which regulates the transcription of multiple virulence genes as 
alpha, beta and delta hemolysins, and exotoxins secreted as virulence factors. 
(11) 
Additionally, S. aureus produce several toxins, such as pyrogenic toxin 
superantigens such as the toxin TSS1, which has been linked to toxic shock 
syndrome and other staphylococcal toxins associated to food poisoning. 
Staphylococcus aureus also can produce exfoliative toxin and which is though 
thought to be responsible  of scalded-skin syndrome (SSS),  hemolysins (alpha, beta, 
and delta) that act on cell membranes , and several two component toxins (like the 
Panton-Valentine leukocidin (PVL) associated with severe necrotizing pneumonia in 
children) (12). 
Nosocomial Epidemiology  
 
The evolution of nosocomial bacteria with virulent phenotype and / or antibiotic 
multi-resistance increases mortality, morbidity and treatment costs. Staphylococcus 
aureus regarded as normal microbiota of nasopharynx but it can produce lower 
respiratory infections, bacteremia, and sepsis (13,8).  
S. aureus could be constitutively resistant to some penicillins, and has been 
classified according this in Meticillin Resistant Staphylococcus aureus (MRSA) and  
Meticillin Sensible Staphylococcus aureus (MSSA). The treatment of choice for 
MRSA is vancomycin which is a very expensive antibiotic (3). Since 1996 have been 
reported strains with intermediate resistance to vancomycin (CIM 8-16ug/ml) and in 
2002 there were reported strains which possessed high resistance genes vanA or 
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vanB originally found in Enterococcus spp (14). The acronyms VISA and GISA 
describe strains of Staphylococcus aureus with intermediate sensitivity to vancomycin 
or glycopeptides. These strains have been reported in Japan, USA, Europe, in Hong 
Kong, and Korea, but the actual prevalence of GISA is unknown (10). There have 
been described strains with heterogeneous resistance (hVISA) which have acquired 
progressive resistance to vancomycin (15,13).  
Staphylococcus aureus is the second most frequent cause of nosocomial 
bacteremia which is three times more frequent in carriers that in no carriers. 
Genotype analysis indicated that 80% of carriers had clones present in the hospital 
workers. A large study conducted on hospital workers fund that about 27.8% of the 
staff of intensive care unit and approximately 31.1% of all hospital staff carried 
Staphylococcus aureus in their nasopharynx (16). The presence of Staphylococcus 
aureus carriers among hospital staff increases the risk of nosocomial infections from 
2 to 3 times in the ICU, dialysis units, or surgical procedures (17).  
It has been reported that the combination of conventional and molecular 
epidemiological analysis of staff and patients, and selective topical treatment 
decreased staphylococcal nosocomial infections from 0.97% to 0.56% (18). Similarly, 
another study found that intervention to  healthy carriers caused a decrease in an OR 
of 0.16 (95% CI 0.04-0.59) in the development of nosocomial infections (19).  
 
 
13 
 
 
 
 
Burkholderia cepacia 
Microbiological characteristics and Epidemiology  
Burkholderia cepacia Complex (CCB) before named as Pseudomonas 
cepacia, is composed of at least nine different species, these species were initially 
referred to as ‘genomovars’ based on their very close phenotypic and phylogenetic 
relatedness. It is a -proteobacteria group of Gram negative aerobic that produces 
catalase (7). The CBC is commonly found in water and soil and can survive long 
periods in moist environments including some common disinfectants. The dispersion 
could be person to person, especially in close environments like hospitals. B. cepacia 
is an important human pathogen that most often causes pneumonia in 
immunocompromised individuals with underlying lung disease like in cystic fibrosis 
patients. Accurate identification of Burkholderia species using routine methods 
continues to be difficult; misidentification as other related species also found in cystic 
fibrosis sputum, such as Pandoraea spp., Ralstonia spp., and Achromobacter spp. is 
common (20).  
The CBC bacterial organisms are naturally resistant to many common antibiotics, 
such as aminoglycosides (gentamicin and tobramycin) and polymyxin B (21). 
Burkholderia spp are being recognized with increasing frequency as 
nosocomial pathogens. Due to their wide distribution in the natural environment, 
nutritional adaptability, and ability to form biofilms, outbreaks of infection in hospitals 
are frequent however the source of these bacteria is seldom identified. Several recent 
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reports identified a variety of infection vehicles, including ultrasound gel, nebulized 
medications, nasal spray, hospital water, and lipid emulsion (22, 23). 
15 
 
 
 
General Introduction Bibliography  
 
1. Zaidi A., Huskins C., Thaver D., Bhutta Z., Abbas Z., Goldmann D. Hospital-acquired 
neonatal infections in developing countries . 2005, Lancet, 365: 1175–88. 
2. Ade y Torrent, MP and Bolis, M. Infecciones Hospitalarias. Washington DC : PAHO 
Documento Técnico HDM/CD/A/500-07, 2007. 
3. Salvatierra-González, Roxane. Costo de la infección nosocomial en nueve países de América 
Latina. Washington, D.C : Organización Panamericana de la Salud, 2003. 
4. Weinstein, R. A.Nosocomial infection update ., Emerg Infect Dis , 4:416-20. 1998 
5. Gerberding, JL. Hospital-Onset Infections: A Patient Safety Issue. Annals of Internal Medicine 
, Vol 137 8:665-672. 2002 
6. Singh A, Goering V, Simjee S, Foley S, Zervos M.Application of Molecular Techniques to the 
Study of Hospital Infection. CLINICAL MICROBIOLOGY REVIEWS,  512–530. 2006, 
7. Ryan, KJ and Ray, CG. Sherris Medical Microbiology. New York city : 4th ed., McGraw Hill, 
2004. 
8. Menichetti, F.Current and emerging serious Gram-positive infections. Clin Microbiol Infect , 
Suppl 3: 22–8. 2005 
9. Sakoulas, G and Moellering, RC.Adaptation of Methicillin-Resistant Staphylococcus aureus in 
the Face of Vancomycin Therapy. Clinical Infectious Diseases, 42:S40–50. 2006. 
10. Sakoulas, G, Eliopoulos, GM and Moellering, RC.Accessory gene regulator (agr) locus in 
geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. . 
Antimicrob Agents Chemother, 46:1492–502. 2002. 
11. Sakoulas, G, Eliopoulos, GM and Moellering, RC.Staphylococcus aureus accessory gene 
regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide 
resistance?. J Infect Dis, 187:929–38. 2003 
12. Jarraud, S, Mougel, C and Thioulouse, J. Relationships between Staphylococcus aureus 
genetic background, virulence factors, agr groups (alleles),and human disease. Infect Immun, 70:631–
41. 2002. 
13. Chambers, HF.The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis, 7 (2): 
178–82. 2001. 
16 
 
 
 
14. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant 
Staphylococcus aureus clinical strain with reduced vancomycin susceptibility., J Antimicrob 
Chemother, 40:135–6. 1997 
15. Wootton, M. and Bennett, P. M. Reduced expression of the atl autolysin gene and susceptibility 
to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and 
GISA strains. 2005, Journal of Antimicrobial Chemotherapy, 56, 944–947. 
16. Rahbar, M, Yaghoobi, M and KiaDarbandsari, B.Prevalence of Nasal Carriage of 
Staphylococcus aureus and Susceptibility of Isolates to Methicillin and Mupirocin Among Healthcare 
Workers in an Iranian Hospital. Infection Control and Hospital Epidemiology, 27:3, 323-325. 
2006 
17. Perl, TM and Golub, JE. New approaches to reduce Staphylococcus aureus nosocomial infection 
rates: treating S. aureus nasal carriage. Ann Pharmacother, 32(1):S7-16. 1998. 
18. Carrier M, Marchand R, Perrault LP, Cartier R, Pagé P.Methicillin-resistant Staphylococcus 
aureus infection in a cardiac surgical unit., Journal of Thoracic and Cardiovascular Surgery,  
123(1): 40-44. 2002 
19. Wertheim HF, van Leeuwen WB, Snijders S, Vos MC, Voss A, Vandenbroucke-Grauls 
CM, Kluytmans JA, Verbrugh HA, van Belkum A. Associations between Staphylococcus aureus 
Genotype, Infection, and In-Hospital Mortality: A Nested Case-Control Study. J Infect Dis. 
192(7):1196-200. 2005 
20. Moreira BM, Leobons MB, Pellegrino FL, et al.Ralstonia pickettii and Burkholderia cepacia 
complex bloodstream infections related to infusion of contaminated water for injection. J Hosp Infect, 
60: 51-55. 2005 
21. Panlilio AL, Beck-Sague CM, Siegel JD, et al.Infections and pseudoinfections due to 
povidone-iodine solution contaminated with Pseudomonas cepacia. Clin Infect Dis , Vol. 14. 1078-
1083. 1992 
22. Heath DG, Hohneker K, Carriker C, et al.Six-year molecular analysis of Burkholderia cepacia 
complex isolates among cystic fibrosis patients at a referral center for lung transplantation. J Clin 
Microbiol, Vol. 40. 1188-1193. 2002 
23. Eberl L, Tümmler B.Pseudomonas aeruginosa and Burkholderia cepacia in cystic fibrosis: 
genome evolution, interactions and adaptation. Int J Med Microbiol. 294(2-3): 123-31. 2004 
 
17 
 
 
 
Paper 1 
 
Staphylococcus aureus outbreak analysis in the Intensive Care Unit 
of the Social Security Hospital in Ecuador 
 Cardenas Aldaz P. 1,  Alarcon M.2, Narvaez I.3, Salazar R.2, Falconí G3 and Trueba G.1 
1
 Institute of Microbiology, Universidad San Francisco de Quito. 
2
 Intensive Care Unit Hospital Carlos Andrade Marín 
3Microbiology Laboratory Hospital Carlos Andrade Marín 
 
Abstract 
Staphylococcus aureus is a frequent cause of nosocomial pneumonia and 
bacteremia. Classical and molecular epidemiology were used to study S. 
aureus outbreaks in Intensive Care Unit (ICU) of the Social Security 
Hospital in Quito. Methods: S. aureus Isolates from 17 patients and 19 
posible personnel carriers were collected from March 2007 to February 
2008 and analyzed by Pulsed-field gel electrophoresis (PFGE) to determine 
the clonal relationships. Results: In this period there were 16 cases of 
nosocomial acquired pneumonia and an outbreak occurred from June to 
September 2007 with 7 different PFGE patterns, isolates fell into 4 clonal 
groups, and 2 groups of clonally-related isolates. Molecular typing failed to 
identify any staphylococcal reservoir among staff members. Discussion: 
The current study demonstrated that one staphylococcal outbreak occurred 
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during the summer of 2007 and it was caused by different bacterial clones. 
An historical analysis of the staphylococcal infections in the Intensive Care 
Unit (ICU) showed an increased incidence during the summer months (June 
to September). The time of the outbreaks coincided with the programmed 
personnel shift. The data suggested that outbreaks were produced by the 
introduction of improperly trained personnel to UCI.  
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Resumen  
Staphylococcus aureus es una causa frecuente de neumonía nosocomial y 
bacteriemia. Técnicas de epidemiología clásica y molecular fueron 
utilizadas para estudiar los brotes epidémicos de S. aureus en la Unidad de 
Cuidados Intensivos (UCI) del Hospital del Seguro Social en Quito. 
Métodos: Los aislamientos de S. aureus de 17 pacientes y 19 posibles 
portadores sanos en el personal, fueron obtenidos a partir de marzo de 
2007 a febrero de 2008 y analizadas por electroforesis de campo pulsado 
(PFGE) para determinar las relaciones clonales. Resultados: En este 
período se identificaron 16 casos de neumonías nosocomiales, y un brote 
epidémico ocurrió entre junio y septiembre de 2007, cuyos aislados 
mostraron 7 diferentes patrones de PFGE; los aislamientos en su mayoría 
pertenecían a 4 grupos clonales, pero existieron además 2 grupos con 
patrones relacionados. La tipificación molecular no logró identificar a la 
fuente de infección entre los miembros del personal de la UCI considerados 
posibles portadores. Discusión: El presente estudio demostró que el brote 
epidémico que se produjo durante el verano de 2007 fue causado por 
bacterias originarias de diferentes clones. Un análisis histórico de las 
infecciones en la Unidad de Cuidados Intensivos (UCI) mostró un aumento 
en la incidencia de S. aureus durante los meses de verano (junio a 
septiembre). El tiempo de los brotes coincidió con la rotación programada 
del personal por vacaciones. Los datos sugirieron que los brotes fueron 
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producidos por la introducción de personal inadecuadamente capacitado en 
la UCI. 
21 
 
 
 
Introduction 
 
Nosocomial infections represent a serious public health problem. In developing 
countries, the rates of nosocomial infections are 3 to 20 times higher than those in 
industrialized countries (1). Infections caused by nosocomial bacteria, many of which 
are resistant to many antimicrobials, increases mortality, morbidity, and treatment 
cost (2).  
Staphylococcus aureus is regarded as normal microbiota of nasopharynx but it 
can produce lower respiratory infections, bacteremia and sepsis (3)(4); indeed, S. 
aureus is the second most frequent cause of nosocomial bacteremia. The presence 
of Staphylococcus aureus carriers among hospital staff increases the risk of 
nosocomial infections from 2 to 3 times in the Intensive Care Unit (ICU), dialysis units, 
or surgical procedures (5). The emergence of methicillin-resistant Staphylococcus 
aureus (MRSA) has increased even more the burden of staphylococcal infections in 
hospitals (6). 
Surveillance is critical in the fight against nosocomial infections, because it 
allows to assess the real impact of these infections and the risk factors associated to 
them. This information enables better decision-making for prevention and control 
measures (7). Molecular typing is an important epidemiological tool which utilizes 
analysis of genetic lineage of pathogens in order to identify the relationship of isolates 
and thus allows the detection of outbreaks, cross-transmission of pathogens, source 
of infection, recognition particularly virulent strains and monitoring of vaccination 
programs (8).  
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 This study is the result of the implementation of an epidemiological surveillance 
system for staphylococcal infections in the Intensive Care Unit (ICU) of the largest 
public hospital in Quito, from March 2007 to February 2008. The goal of the study 
was to determine the origin and the factors involved in the occurrence of 
staphylococcal outbreaks in this hospital. 
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Materials and Methods  
Subjects 
The study was performed in Carlos Andrade Marín Hospital in Quito, a 300-
bed tertiary care center. The ICU has 18 beds admitting critically ill patients. This 
study was previously reviewed and accepted by the Bioethics Committee of San 
Francisco de Quito University and by Bioethics Committee of Carlos Andrade Marín 
Hospital.  
We analyzed 17 isolates from patients collected over one year period (March 
2007 to February 2008). All patients with confirmed nosocomial acquired S. aureus 
were asked to fill out  an outbreak analysis form (Annex 1) containing  cause of 
admission, co-morbidities, time in hospital, bed location, and type of nosocomial 
infection.  
Also, there were screened 43 health workers of ICU, and we obtained 19 S. 
aureus isolates from their nasopharynx as potential nosocomial bacteria carriers.  
Statistical analysis was conducted by STAT VIEW version 5.0 and Microsoft Excel 
2007. We used odds ratio test to determine the likelihood of patients acquiring MRSA 
infections when undergoing antibacterial prophylaxis. 
Bacterial isolates 
 
A total of 17 S. aureus isolates from inpatients with pneumonia were collected from 
March 2007 to February 2008 from Carlos Andrade Marín Hospital in Quito. Nineteen 
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strains were obtained from nasal samples of 43 health workers from the Intensive 
care unit. Samples were cultivated in Manitol medium and identified as S. aureus with 
coagulase test. Then, isolated colonies were cultured in BHI medium and stored at -
80°C. 
Isolates from patients were named as P1 to P17 according the chronological date of 
isolation. Isolates from carriers were named according the occupation of each carrier: 
assistant nurse (A), assistant nurse 2 (C), nurse (E), respiratory physioterapist (F), 
cleaning staff person (L), medical doctor (M), personnel in charge of equipment 
maintenance (Q), and secretary (S).  
Antimicrobial sensitivity profiles 
 
Antibiotic susceptibility tests were carried out by disk diffusion method using Mueller-
Hinton agar. The antimicrobial agents tested included cephoxitin (FOX), erythromycin 
(E), clindamycin (DA), nofloxacin (NOR), vancomycin (VA) and penicillin (P).  
Pulsed Field Gel Electrophoresis  
Isolates were analyzed by pulsed-field gel electrophoresis (PFGE).  A sample 
of each isolate of S. aureus was plated into brain-heart infusion agar and incubated 
overnight at 37°C.  Agarose plugs were prepared by mixing 200µl of a bacterial 
suspension in 75 mM NaCl–25 mM EDTA (pH 7.5) buffer  (absorbance of 0.63 OD (± 
0.02) a 610 nm) with 200 µl molten solution of 1% BioRad PFGE agarose in 0.5TBE 
0,5X , 1% SDS solution containing 4 g of lysostaphin (Sigma-Aldrich, Oakville, 
Ontario, Canada). Cells were lysed in situ at 37°C for 4 h in lysis buffer (6 mM Tris-
HCl [pH 8.0], 1 M NaCl, 100 mM EDTA, 0.5% Brij-58, 8 g of lysostaphin, 0.5% 
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sodium lauroylsarcosine). Cells in plugs were lysed overnight at 50°C in 1.5 ml of 
lysis buffer (50 mM Tris, 50mM EDTA, 1% Sarcosil) containing 0,8 mg of Proteinase 
K (Bio-Rad Laboratories). The plug slices were washed with sterile water and TE and 
each plug was digested overnight at 30°C in 100 µL of React4 Buffer, BSA 1 µl and 
10 U SmaI restriction enzyme. The slices were loaded into a 1% agarose gel, and 
DNA was separated by PFGE using a CHEF DRII system (Bio-Rad) in 0.5X TBE 
Buffer with pulse times of 5 to 40 s at 6 V/cm for 21h at 14°C. Concatameric 
bacteriophage lambda DNA molecules were used as molecular weight standard (New 
England Biolabs) (9).  
     The PFGE patterns of the clinical isolates were compared and clonal relatedness 
was established based on the recommendations of Tenover et al (10,11).  
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Results 
Isolates from patients 
A total of 17 strains were isolated during one year study. The characteristics of 
the isolates are summarized in Table 1.  The most common nosocomial infection was 
ventilator-associated pneumonia (12 patients), the most common cause of admission 
was severe cranium-encephalic trauma (9 patients), and there were isolated 9 
meticillin sensible Staphylococcus aureus (MSSA) and 8 meticillin resistant 
Staphylococcus aureus (MRSA). An evident outbreak occurred from July and 
September 2007 with 11 cases of nosocomial acquired pneumonia (Fig 4). Statistical 
analysis for relation between S. aureus type and antibiotic prophylaxis did not prevent 
the acquisition of MRSA infections (Odds Ratio=2,28).  
Clonal Analysis of Isolates  
Analysis of isolates showed 12 different PFGE patterns. There were 4 groups 
of isolates with identical PFGE patterns, and 2 groups that had related profiles.  The 
groups of isolates with identical PFGE pattern were: P4 and P10 (isolated in July and 
August 2007), P5 and P6 (isolated in July 2007), P15 and P16 (isolated in November 
and December 2007), and P13, P14, and P17 isolated in September, October 2007 
and February 2008) (Fig 2 and 3) (Table 3). 
The first partial relation was between P4 and P10 with P8 (Pattern IVa and 
IVb).   The second partial relation was between P13, P14 and P17 with P12 (Pattern 
IXb and IXa) (Fig 2 and 3) (Table 3). Isolates P13, P14 and P17 have an identical 
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PFGE pattern (IXb) but a different antimicrobial sensitivity profile (g, h and c) (Table 
3).   
An isolate from community acquired pneumonia (isolate P7) was used as 
unrelated isolate (Fig 2 and 3). All the relations were supported in phylogenetic 
analysis by UPGMA with DICE coefficient (Fig 4). The distribution of PFGE patterns 
in time shows the circulation of a variety of clones during the outbreak between July 
2007 and February 2008 (Fig 5). 
Potential Carriers 
Although there were staff members carrying Staphyloccoccus aureus, none of 
their isolates was involved in the pneumonia outbreaks (Fig 6 and 7).  
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Discussion 
 
The present report describes an outbreak of Staphylococcus aureus which 
took place from July to September 2007 in the ICU of the largest public hospital in 
Quito.  Molecular characterization of the infecting isolates in the outbreak showed 7 
different bacterial clones and there was no relationship with Staphylococcus aureus 
isolated from personnel. The outbreak occurred from June to September, which 
coincided with rotation of personnel due to vacation. We were able to detect another 
outbreak of Staphylococcus aureus, during the same period of time in the year 2006.  
The data strongly suggests that the outbreak was caused by the introduction of 
improperly trained personnel to ICU.  This report is in contrast to previous studies in 
which they were healthcare workers, the ones who carried the bacteria and infected 
patients (12,13,14) and outbreaks usually are caused by a limited number of clones 
(15,16,17,18). 
One clone (PFGE pattern IXb) was isolated from cases occurring from 
September 2007 to February 2008. These finding may indicate that some strains 
could have been carried by personnel or other patients during this time, however we 
failed to identify them (80% of the staff was screened once).  
Epidemiological analysis shows that the most common risk factor of acquiring 
a nosocomial infection by S. aureus was the use of mechanic ventilation.  Indeed, the 
most prevalent nosocomial infection was ventilator associated pneumonia. All the 
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patients with Ventilator Associated Pneumonia had others risk factors such as 
catheter enteric nutrition and previous surgery. Interestingly, there was a higher risk 
of acquire a MRSA strain when using antibiotic prophylaxis.  
In conclusion, there were 7 main clusters of S. aureus circulating in the ICU 
during June and September 2007, and caused a multiclonal outbreak. This study, 
suggested that changes in personnel of ICU may have been the principal cause of 
high rates transmission of S. aureus. The study suggests that improper sanitation of 
the hands and equipment during manipulation of the breathing tubes and gastric 
catheters may have contributed to the spread of the staphylococcal infection among 
patients.  
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Investigation of an Outbreak of Central Venous Catheter–Associated 
Bloodstream Infection Due to Contaminated Water 
Richard W. Douce, MD; Jeannete Zurita, MD; Olga Sanchez, RN;  
Paul Cardenas Aldaz, MD 
Abstract 
 
We report an outbreak of infections transmitted by the central venous line catheters in 
a small hospital of Ecuador. We found ampoules of reportedly sterile water for 
injection to be contaminated with Burkholderia cepacia and Myroides odoratus. 
Retrospective review of charts revealed that the problem had been present in Quito 
for 18 months. Pulse field gel electrophoresis (PFGE) suggested clonality between 
the clinical isolates of B. cepacia with the isolates from the ampoules of sterile water.  
Some of the patients with bacteremia due to Burkholderia cepacia had severe 
symptoms. In some cases we also isolated Myroides odoratus from the blood of 
infected patients, but in this case it did not present symptoms of infection. .  Isolation 
of Burkholderia cepacia from blood obtained from reportedly “sterile ampoules” 
indicates the importance of monitoring of solutions for injection used in health care 
institutions. 
34 
 
 
 
 
Resumen  
 
Este estudio presenta el análisis de un brote epidémico de infecciones transmitidas 
por catéteres de vía central que ocurrió en un pequeño hospital de Ecuador. Al 
parecer se han encontrado ampollas de agua estéril para inyección contaminados 
con Burkholderia cepacia y Myroides odoratus. La revisión retrospectiva de historias 
clínicas determinó que el problema había estado presente durante los últimos 18 
meses en este hospital. El análisis mediante electroforesis de campo pulsado 
(PFGE) sugiere clonalidad entre los aislados clínicos de B. cepacia con los 
aislamientos de las ampollas de agua estéril. Algunos de los pacientes con 
bacteriemia debido a Burkholderia cepacia desarrollaron síntomas graves. En 
algunos casos también Myroides odoratus fue aislado de hemocultivos de pacientes 
infectados, pero en este caso los pacientes no presentaron síntomas de infección. El 
aislamiento de Burkholderia cepacia de sangre obtenida de supuestas "ampollas 
estériles" indica la importancia de la vigilancia de las soluciones utilizadas para la 
inyección en las instituciones de salud. 
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Introduction 
An outbreak of central venous catheter–associated bloodstream infections was 
reported in a hospital in Ecuador. Commercially produced ampoules of water for 
injection were found to be contaminated with Burkholderia cepacia and Myroides 
odoratus. Removal of these ampoules yielded a 10-fold reduction in the incidence of 
catheter-associated infection. 
Burkholderia cepacia is a rare cause of bloodstream infection (BSI). It has been 
isolated from solutions for disinfection1-3 and from water,2 and has been implicated in 
several nosocomial outbreaks. We report an investigation of an outbreak after 4 
patients with central venous catheters (CVCs) were identified as having bacteremia 
due to B. cepacia in September 2006. The objective of the investigation was to 
identify and eradicate the source of B. cepacia contamination. 
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Methods 
 
Setting and participants. The setting was an acute care teaching hospital in 
Ecuador with a total of 75 beds, of which 8 were in the intensive care unit. The study 
was performed by the infection control committee, which includes a part-time nurse 
epidemiologist (O.S.), a part-time infection control physician (R.D.), a microbiologist 
(J.Z.), and representatives of the nursing staff. 
Case definition and laboratory methods. A case patient was defined as a patient 
with a CVC who had a culture of peripheral blood sample, of blood drawn from the 
catheter, or of the catheter tip that was positive for B. cepacia. All results of routine 
cultures for current patients and all medical records from patients whose blood 
cultures were positive for B. cepacia were reviewed, and all isolates from culture were 
saved for further analysis. Results of cultures performed at the hospital during the 
preceding 2 years and procedures for obtaining blood samples for culture and for 
placing CVCs were also reviewed. Samples were obtained for culture from all the 
materials used for catheter maintenance, including povidone iodine, alcohol swabs, 
and heparin for flushing lines. Finally, the medical records of the index patients were 
reviewed to see what medicines they received in common between the date of 
admission and the date of the first positive blood culture result. Samples of those 
medicines and their diluents were cultured. 
Blood cultures were performed using an automated system (Bactec 9120; Becton 
Dickinson). The organisms isolated were identified by conventional methods, by the 
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ERIC Electronic Rapid Compendium (Remel), and by the MicroScan system NC32 
(Siemens Medical Solutions Diagnostics). Catheter tips were cultured using the 
technique described by Maki et al.4 Liquids were cultured by direct inoculation into 
blood culture bottles. 
Isolates were submitted for analysis by pulsed-field gel electrophoresis (PFGE) using 
the methods described by Heath et al.5 The PFGE patterns of the clinical isolates 
were compared, and clonality was identified on the basis of the recommendations of 
Tenover et al.6  
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Results 
 
After the identification of 4 patients with CVC-associated BSI, there was concern 
about a possible outbreak, and we subsequently identified 8 patients retrospectively 
and 4 patients prospectively who fit the case definition. The Figure 1 gives the 
temporal distribution of these case patients. All 16 patients had CVCs made of 
polyurethane and had been in the intensive care unit sometime during their 
hospitalization. Two of the 16 patients had no fever and were initially considered to 
have pseudobacteremia. They were identified on the basis of cultures of blood 
obtained at the time CVC use was discontinued after a surgical procedure. Four 
patients had recurrent low-grade fever and had blood cultures that were positive for 
B. cepacia within 4 days after catheter removal. One of these patients was found to 
have sepsis with multiorgan failure and persistent bacteremia after removal of the 
catheter; this patient finally improved 11 days later after beginning use of 3 
intravenous antibiotics. After B. cepacia was identified in the other 3 patients, they 
were treated with oral trimethoprim and sulfamethoxazole and did well. Five of the 16 
patients died of the disease process for which they were hospitalized.  
The 5 remaining patients had no apparent complications. After performing 47 cultures 
of disinfectants and solutions used for catheter maintenance, we finally isolated B. 
cepacia from 5-mL glass ampoules of reportedly sterile water used to dilute antibiotics 
for infusion. Quantitative culture of this commercial product revealed 3,000 cfu/mL of 
B. cepacia and 10 cfu/mL of Myroides odoratus. Four different lots of ampoules of 
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water for injection from the same manufacturer were found in the hospital pharmacy. 
Samples of the ampoules of water from each lot were uniformly culture-positive for 
the same organisms. The pharmacy had been purchasing water ampoules from this 
source for 18 months before the outbreak was identified. Five isolates of B. cepacia 
recovered from patients in this investigation and 3 isolates recovered.  
After M. odoratus was identified in the commercial water, we performed a 
retrospective review of the medical records and found that 21 blood cultures had 
been positive for M. odoratus. All of them had been considered to represent 
pseudobacteremia before this investigation. No patient had both M. odoratus and B. 
cepacia isolated from blood culture. All but 1 of the isolates of M. odoratus and B. 
cepacia were recovered during the period when the implicated water was being used 
by the hospital pharmacy. As soon as the commercial water was confirmed to be 
contaminated with B. cepacia and M. odoratus, the product was removed from the 
hospital, and a formal report was submitted to the Ecuador Ministry of Health. Intrinsic 
contamination of the water was confirmed by the National Microbiology Laboratory. 
Information on the number of catheter-days was available for the 2 months that 
included the case identification and prospective study. During that time, there were 8 
CVC-associated infections during 263 catheter-days (30 infections per 1,000 
catheter-days). During the 10 months after removal of the implicated water, no further 
isolates of either B. cepacia or M. odoratus were recovered from blood samples, and 
a total of 3 CVC-associated infections occurred in our hospital during 877 catheter-
days (3.4 infections per 1,000 catheter-days).  
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Discussion 
 
B. cepacia is not an organism that typically infects CVCs.7 At the beginning of the 
outbreak, few B. cepacia isolates were recovered, and the organism was not 
consistently isolated each month. A full investigation was not initiated until after 
sepsis due to B. cepacia was documented in a patient and after several patients had 
the same organism recovered from blood in the same month. 
M. odoratus is common in soil and water but is rarely isolated from patients.8 It was 
not considered pathogenic in any of our patients, and, as a contaminant, it was 
inappropriately attributed to a faulty procedure in obtaining blood samples for 
culture—until after it was isolated from the contaminated commercial product. In the 
literature, it has been implicated in cellulitis and bacteremia associated with catheters 
and is considered to be resistant to carbapenems, lactams,and aminoglycosides.8 
This outbreak was caused by commercial ampoules of sterile water intrinsically 
contaminated by 2 different bacteria. Sterile water for injection has been implicated in 
outbreaks of bacteremia due to B. cepacia in other countries.9,10 Isolation of B. 
cepacia or M. odoratus from the blood of patients should stimulate investigation that 
includes the culture of any commercial product that contains water that has been 
involved in the treatment of those patients. 
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Table 1. Epidemiological analysis of all patient samples. It shows the date of isolation, age, gender, type of 
infection.  
 *Community acquired Pneumonia   
  
 
 
 
 
 
 
 
Isolate 
ID 
Date of 
isolation 
Mechanic 
Ventilation Sample PFGE Group 
P-001 may-07 + Trachea I 
P-002 jun-07 + Trachea II 
P-003 jun-07 + Trachea III 
P-004 jul-07 + Trachea IVa 
P-005 jul-07 + Trachea V 
P-006 jul-07 + Trachea V 
P-007* ago-07 - Trachea VI 
P-008 ago-07 + Trachea IVb 
P-009 ago-07 + Blood VII 
P-010 ago-07 - Trachea IVa 
P-011 ago-07 - Trachea VIII 
P-012 ago-07 + Trachea IXa 
P-013 sep-07 + Trachea IXb 
P-014 oct-07 + Trachea IXb 
P-015 nov-07 + Trachea X 
P-016 dic-07 + Blood X 
P-017 feb-08 + Trachea IXb 
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Figure 1 . PFGE analysis of Patients´ isolates from 1 to 17 (P1 to P17), Lambda Ladder (L), 
Negative control (C-). 
  
 
 
 
 
 
 
 
47 
 
 
 
 
 
Figure 2 . PFGE analysis of Patients´ isolates grouped by similar PFGE patterns from 3 to 17 (P3 
to P17), Lambda Ladder (L), Negative control (C-). 
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ISOLATE DATE TYPE ANTIBIOTIC PATTERN 
PFGE 
PATTERN  
P-001 may-07 MRSA a I 
P-002 jun-07 MSSA b II 
P-003 jun-07 MSSA c III 
P-004 jul-07 MRSA d IVa 
P-005 jul-07 MRSA d V 
P-006 jul-07 MRSA d V 
P-007 ago-07 MSSA e VI 
P-008 ago-07 MRSA d IVb 
P-009 ago-07 MSSA e VII 
P-010 ago-07 MRSA d IVa 
P-011 ago-07 MSSA f VIII 
P-012 ago-07 MSSA e IXa 
P-013 sep-07 MSSA g IXb 
P-014 oct-07 MSSA h IXb 
P-015 nov-08 MRSA d X 
P-016 dic-08 MRSA d X 
P-017 feb-08 MSSA c IXb 
 
Table 2. Antimicrobial and Molecular typing of all patients´ isolates. It is showed antibiotic 
patterns and PFGE patterns.  
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Figure 3. UPGMA tree constructed with the PFGE profiles obtained from staphylococcal isolates. 
DICE coefficient was used. 
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Figure 4. Time distribution of  Staphyloccocus aureus PFGE patterns . The vertical axes 
indicate the number of staphyloccal infections.
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Figure 5 . PFGE analysis of Patient 2 isolate (P2) compared with assistant nursing 2 (A2),  
stretcher bearer 1 (C1),  nurse 12 (E12), respiratory physiotherapist 1 (F1), cleaning staff person 
2 (L2), medical doctor 9 (M9),  medical equipment repair staff person 1 (Q1), secretary 1 (S1), 
Lambda Ladder (L), Negative control (C-) and unrelated isolate from patient 3 (P3).  
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Figure 6 . PFGE analysis of Patient 3 isolate (P3) compared with isolates M5, M6, M8. Lambda 
Ladder (L), Negative control (C-) and unrelated isolate from S. aureus ATCC (AT).  
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Figure 7. Temporal distribution of case patients investigated, by month. O, Myroides odoratus isolated 
from the blood of a patient; X, Burkholderia cepacia isolated from blood or catheter tip of a patient with 
a central venous catheter. from samples of these commercial ampoules of water were analyzed by 
PFGE and were shown to have identical banding patterns. 
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Annex 1.  Nosocomial 
Infection Formulary: 
outbreak analysis form 
containing cause of 
admission, co-
morbidities, time in 
hospital, bed location, 
and type of nosocomial 
infection  
 
 
